These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 573084)

  • 21. Aluminum and phosphate.
    Kaye M; Turner M; Ardila M; Wiegmann T; Hodsman A
    Kidney Int Suppl; 1988 Mar; 24():S172-4. PubMed ID: 3163042
    [No Abstract]   [Full Text] [Related]  

  • 22. [Progressive dialytic encephalopathy].
    Rabey JM; Blum M; Vardi J; Aviram A; Moriel EZ; Streifler M
    Harefuah; 1980 Mar; 98(5):205-7. PubMed ID: 7409633
    [No Abstract]   [Full Text] [Related]  

  • 23. The efficacy of various treatment modalities on aluminium associated bone disease.
    Ihle BU; Buchanan MR; Stevens B; Becker GJ; Kincaid-Smith P
    Proc Eur Dial Transplant Assoc; 1983; 19():195-202. PubMed ID: 6348735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
    Milliner DS; Hercz G; Miller JH; Shinaberger JH; Nissenson AR; Coburn JW
    Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of desferrioxamine in the treatment of dialysis encephalopathy.
    Ackrill P; Ralston AJ; Day JP
    Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
    [No Abstract]   [Full Text] [Related]  

  • 26. Dialysis encephalopathy.
    Schreeder MT
    Arch Intern Med; 1979 May; 139(5):510-1. PubMed ID: 443942
    [No Abstract]   [Full Text] [Related]  

  • 27. Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
    Nebeker HG; Andress DL; Milliner DS; Ott SM; Alfrey AC; Slatopolsky EA; Sherrard DJ; Coburn JW
    Kidney Int Suppl; 1986 Feb; 18():S96-9. PubMed ID: 3458006
    [No Abstract]   [Full Text] [Related]  

  • 28. [Adynamic bone disease in kidney failure. Role of aluminum].
    Cohen-Solal ME; Sebert JL; Morinière P; Fournier A
    Rev Rhum Ed Fr; 1993 May; 60(5):361-4. PubMed ID: 8167643
    [No Abstract]   [Full Text] [Related]  

  • 29. Aluminum and renal bone disease in Australia.
    Dunstan CR; Evans RA
    Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999
    [No Abstract]   [Full Text] [Related]  

  • 30. Dialysis dementia.
    Mach JR; Korchik WP; Mahowald MW
    Clin Geriatr Med; 1988 Nov; 4(4):853-67. PubMed ID: 3066464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysis dementia: the role of dialysate pH in altering the dialyzability of aluminum.
    Gacek EM; Babb AL; Uvelli DA; Fry DL; Scribner BH
    Trans Am Soc Artif Intern Organs; 1979; 25():409-15. PubMed ID: 43004
    [No Abstract]   [Full Text] [Related]  

  • 32. [Aluminum and dialysis].
    Rosenlöf K; Honkanen E
    Duodecim; 1991; 107(11):898-900. PubMed ID: 1364734
    [No Abstract]   [Full Text] [Related]  

  • 33. Drugs as a hidden source of aluminium for chronic renal patients.
    Bohrer D; Bertagnolli DC; de Oliveira SM; do Nascimento PC; de Carvalho LM; Pomblum SG
    Nephrol Dial Transplant; 2007 Feb; 22(2):605-11. PubMed ID: 17035374
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosis and treatment of aluminium overload in end-stage renal failure patients.
    Nephrol Dial Transplant; 1993; 8 Suppl 1():1-4. PubMed ID: 8389013
    [No Abstract]   [Full Text] [Related]  

  • 35. More on aluminum, pteridine, and dialysis dementia.
    Dhondt JL
    N Engl J Med; 1988 Mar; 318(9):582-3. PubMed ID: 3340139
    [No Abstract]   [Full Text] [Related]  

  • 36. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 37. Aluminum-associated bone disease: what's in a name?
    Quarles LD; Gitelman HJ; Drezner MK
    J Bone Miner Res; 1986 Oct; 1(5):389-90. PubMed ID: 3503553
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hemodialysis dementia].
    Egídio J; Júnior R; Ianhez LE; Sabbaga E
    AMB Rev Assoc Med Bras; 1980 Aug; 26(8):261-3. PubMed ID: 6970943
    [No Abstract]   [Full Text] [Related]  

  • 39. [Practical considerations on aluminum hazards in uremic patients on dialysis].
    Gilli P; Malacarne F
    Minerva Nefrol; 1982; 29(4):233-4. PubMed ID: 7155444
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dialysis dementia].
    Firmat J
    Medicina (B Aires); 1986; 46(3):361-2. PubMed ID: 3574095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.